PrimeVax Immuno-Oncology Company
PrimeVax Immuno-Oncology is developing a multi-mechanism treatment for cancer leveraging whole body systemic.
Technology:
CAR-T therapy, Cell-based gene therapy
Industry:
Private
Headquarters:
Orange, California, United States
Founded Date:
2015-01-01
Employees Number:
1-10
Estimated Revenue:
Less than $1M
Register and Claim Ownership